TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/5/23 21:06 | 11/30/23 | IMGN | Immunogen, Inc. | MA | Health | Drug | Pharmaceutical Preparations | Peterson Kristine | MA | D | M.d | 232 | 11.59 | 0 | 20 | 0 | D | ||||||||||||||||
12/5/23 21:06 | 11/30/23 | IMGN | Immunogen, Inc. | MA | Health | Drug | Pharmaceutical Preparations | Peterson Kristine | MA | D | S.d | -578 | 28.90 | 0 | -20 | -100 | 0 | D | |||||||||||||||
9/14/23 17:31 | 9/13/23 | IMGN | Immunogen, Inc. | MA | Health | Drug | Pharmaceutical Preparations | Peterson Kristine | MA | D | M.d | 308 | 15.39 | 0 | 20 | 0 | D | ||||||||||||||||
6/24/19 16:29 | 6/21/19 | EYPT | Eyepoint Pharmaceuticals, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Peterson Kristine | MA | D | M.d | 0 | 0.00 | 0 | 7 | New | 7 | D | |||||||||||||||
2/22/19 21:32 | 2/22/19 | AMRN | Amarin Corp Plcuk | X0 | Health | Drug | Pharmaceutical Preparations | Peterson Kristine | NJ | D | M.d | 948 | 5.80 | 0 | 164 | 0 | D | ||||||||||||||||
2/22/19 21:32 | 2/22/19 | AMRN | Amarin Corp Plcuk | X0 | Health | Drug | Pharmaceutical Preparations | Peterson Kristine | NJ | D | S.d | -3,274 | 20.02 | 0 | -164 | -100 | 0 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |